secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76231 grounded facts newest August 28, 2026, 4:49 PM ET RSS · JSON

Showing 901–950 of 18616

Role change (interim)

Nelson Urdaneta

Senior Vice President and Chief Financial Officer
KMB · KIMBERLY CLARK CORP
Effective
2026-05-22
Filed
May 5, 2026, 7:59 PM ET
The Corporation’s Senior Vice President and Chief Financial Officer, Nelson Urdaneta, will act as the Corporation’s principal accounting officer effective upon Mr. Scribner’s departure on an interim basis and in addition to his current duties.
Appointed

Alton Shader

Chief Executive Officer
SHC · Sotera Health Co
Effective
2026-05-26
Successor
Alton Shader
Filed
May 5, 2026, 7:59 PM ET
the Board, at the recommendation of the Nominating and Corporate Governance Committee, appointed Alton Shader to serve as Chief Executive Officer of the Company ("CEO") and a Class II director of the Board, effective as of May 26, 2026
Departed

Amanda Whalen

Chief Financial Officer
KVYO · Klaviyo, Inc.
Effective
2026-08-21
Filed
May 5, 2026, 7:59 PM ET
On May 1, 2026, Amanda Whalen informed the Company of her intention to step down from her role as Chief Financial Officer of the Company.
Departed

Michelle Hook

Chief Financial Officer
PTLO · Portillo's Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
On April 30, 2026, Michelle Hook informed the Chief Executive Officer and General Counsel and Secretary of Portillo’s Inc. (the “Company”) that she will depart from her role as Chief Financial Officer of the Company, effective May 5, 2026.
Appointed

Susan Buchanan

Vice President and Chief Accounting Officer (principal accounting officer)
XOM · EXXON MOBIL CORP
Effective
2026-07-01
Filed
May 4, 2026, 7:59 PM ET
On April 28, 2026, the Corporation elected Susan Buchanan as Vice President and Chief Accounting Officer (principal accounting officer) of the Corporation effective July 1, 2026.
Appointed

Richard A. Jackson

President and Chief Executive Officer
OXY · OCCIDENTAL PETROLEUM CORP /DE/
Effective
2026-06-01
Filed
May 4, 2026, 7:59 PM ET
On April 30, 2026, as part of its management succession planning, the Board unanimously approved the appointment of Richard A. Jackson, 50, as Occidental’s President and CEO and as a member of the Board, in each case effective as of the Transition Date.
Departed

Vicki Hollub

President and Chief Executive Officer
OXY · OCCIDENTAL PETROLEUM CORP /DE/
Effective
2026-06-01
Successor
Richard A. Jackson
Filed
May 4, 2026, 7:59 PM ET
On April 30, 2026, Vicki Hollub, President and Chief Executive Officer (“CEO”) of Occidental Petroleum Corporation (“Occidental”), informed the Board of Directors of Occidental (the “Board”) of her decision to retire, effective as of June 1, 2026 (the “Transition Date”).
Appointed

Theodora Mistras

Corporate Vice President, Chief Financial Officer
EW · Edwards Lifesciences Corp
Effective
2026-05-29
Filed
May 4, 2026, 7:59 PM ET
On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.
Departed

James Rinn

Chief Financial Officer
PSQH · PSQ Holdings, Inc.
Effective
2026-04-30
Filed
May 4, 2026, 7:59 PM ET
James Rinn provided notice to PSQ Holdings, Inc. (the “Company”) of his resignation from the position of Chief Financial Officer of the Company, effective April 30, 2026.
Appointed

Ying Luo

Chief Executive Officer, President, Director
GYRE · GYRE THERAPEUTICS, INC.
Effective
2026-05-04
Filed
May 4, 2026, 7:59 PM ET
effective immediately after the Effective Time, the Company appointed Ying Luo, Ph.D. as Chief Executive Officer and President of the Company and to the Board as a Class I director.
Departed

Ruoyu Chen

Chief Financial Officer
GYRE · GYRE THERAPEUTICS, INC.
Effective
2026-05-04
Successor
Thomas Eastling
Filed
May 4, 2026, 7:59 PM ET
Ruoyu Chen, who resigned from her position as Chief Financial Officer on such date.
Appointed

Thomas Eastling

Chief Financial Officer
GYRE · GYRE THERAPEUTICS, INC.
Effective
2026-05-04
Filed
May 4, 2026, 7:59 PM ET
the Company appointed Thomas Eastling as Chief Financial Officer of the Company, to succeed Ruoyu Chen, who resigned from her position as Chief Financial Officer on such date.
Appointed (interim)

Paul Campbell

interim Chief Financial Officer
VTRS · Viatris Inc
Effective
2026-05-08
Filed
May 4, 2026, 7:59 PM ET
On May 4, 2026, the Board of Directors of the Company (the “Board”) appointed Paul Campbell, Viatris’ current Chief Accounting Officer and Corporate Controller, to also serve as interim Chief Financial Officer of the Company, effective May 8, 2026, until a permanent Chief Financial Officer is appointed by the Board.
Departed (interim)

Theodora Mistras

Chief Financial Officer
VTRS · Viatris Inc
Effective
2026-05-08
Successor
Paul Campbell
Filed
May 4, 2026, 7:59 PM ET
On May 1, 2026, Theodora (“Doretta”) Mistras informed Viatris Inc. (the “Company”) that she would voluntarily cease to serve as Chief Financial Officer to pursue another professional opportunity.
Departed

Elisabet de los Pinos

Chief Executive Officer and President
AURA · Aura Biosciences, Inc.
Effective
2026-04-30
Successor
Natalie Holles
Filed
May 4, 2026, 7:59 PM ET
Dr. Elisabet de los Pinos, the Company’s founder, who has notified the Company of her departure from her role at the Company as Chief Executive Officer and President and as a director of the Company, effective as of the Effective Date
Appointed

Natalie Holles

Chief Executive Officer and President
AURA · Aura Biosciences, Inc.
Effective
2026-04-30
Successor
Natalie Holles
Filed
May 4, 2026, 7:59 PM ET
the Board of Directors (the “Board”) of Aura Biosciences, Inc. (the “Company”) appointed Natalie Holles as the Company’s Chief Executive Officer and President and as a Class I director with a term expiring at the Company’s 2028 annual meeting of stockholders, effective as of April 30, 2026
Appointed

Brian Burkavage

principal financial officer and principal accounting officer
DMRA · Damora Therapeutics, Inc.
Effective
2026-05-01
Filed
May 4, 2026, 7:59 PM ET
the Board appointed Brian Burkavage, the Company’s current Senior Vice President, Finance, to serve as the Company’s principal financial officer and principal accounting officer, effective as of the Effective Time.
Departed

Lori Firmani

Chief Financial Officer
DMRA · Damora Therapeutics, Inc.
Effective
2026-05-01
Successor
Brian Burkavage
Filed
May 4, 2026, 7:59 PM ET
the Board of Directors (the “Board”) of Damora Therapeutics, Inc. (the “Company”) determined that, effective as of May 1, 2026 (the “Effective Time”), Lori Firmani would cease serving as the Company’s Chief Financial Officer.
Departed

Paul E. Davis

Chief Executive Officer
ADEA · Adeia Inc.
Filed
May 4, 2026, 7:59 PM ET
On May 4, 2026, Adeia Inc. (the “Company” or “Adeia”) announced that Paul E. Davis, the Company’s chief executive officer, notified the Company and the Board of Directors (the “Board”) on May 4, 2026, of his intention to step down as the Company’s chief executive officer and as a member of the Board to focus on his health and personal pursuits.
Appointed

Paul DiCicco

Executive Vice President, Chief Financial Officer and Treasurer
MSGS · Madison Square Garden Sports Corp.
Effective
2026-05-11
Successor
Paul DiCicco
Filed
May 4, 2026, 7:59 PM ET
On April 28, 2026, the Board of Directors of Madison Square Garden Sports Corp. (the "Company") appointed Paul DiCicco as Executive Vice President, Chief Financial Officer and Treasurer effective May 11, 2026 or such later date as may be agreed (the "Commencement Date").
Appointed

John B. Watwood

President and Chief Executive Officer
POOL · POOL CORP
Effective
2026-05-04
Filed
May 4, 2026, 7:59 PM ET
The Board has appointed John B. Watwood as President and Chief Executive Officer, effective as of the Transition Effective Time.
Departed

Peter D. Arvan

President and Chief Executive Officer
POOL · POOL CORP
Effective
2026-05-04
Successor
John B. Watwood
Filed
May 4, 2026, 7:59 PM ET
On May 4, 2026, Pool Corporation (the “Company”), a Delaware corporation, and Peter D. Arvan mutually agreed that Mr. Arvan will cease to serve as President and Chief Executive Officer, effective May 4, 2026
Departed

Matt Kaplan

President and Chief Executive Officer
GECC · Great Elm Capital Corp.
Effective
2026-05-01
Successor
Jason W. Reese
Filed
May 4, 2026, 7:59 PM ET
Upon Mr. Reese's assumption of this role, Matt Kaplan, who was appointed President and Chief Executive Officer of the Company effective March 4, 2022, concluded his service as the Company's President and Chief Executive Officer.
Appointed

Jason W. Reese

Chief Executive Officer
GECC · Great Elm Capital Corp.
Effective
2026-05-01
Filed
May 4, 2026, 7:59 PM ET
On May 1, 2026, the Company's board of directors appointed Jason W. Reese to serve as the Company’s Chief Executive Officer effective immediately following the filing of the Company’s Form 10-Q for the period ended March 31, 2026.
Role change

Eric Sherb

Chief Financial Officer
UGRO · urban-gro, Inc.
Effective
2026-04-28
Filed
May 4, 2026, 7:59 PM ET
Following Mr. Akright’s resignation, Eric Sherb, who has been serving as Co-Chief Financial Officer, will continue to serve as the Company’s Chief Financial Officer.
Departed

Richard Akright

Co-Chief Financial Officer
UGRO · urban-gro, Inc.
Effective
2026-04-28
Filed
May 4, 2026, 7:59 PM ET
Effective as of April 28, 2026, Richard Akright advised the Company that he was resigning from his position as Co-Chief Financial Officer of urban-gro, Inc. (the “Company”), with such resignation becoming effective on such date.
Appointed

Andrew Olson

Chief Financial Officer
HTGC · Hercules Capital, Inc.
Effective
2026-05-18
Filed
May 4, 2026, 7:59 PM ET
Andrew Olson, age 43, was appointed Chief Financial Officer and Head of Corporate Development, succeeding Mr. Meyer in the role of Chief Financial Officer.
Departed

George Furlan

Interim Chief Executive Officer
SNBH · SENTIENT BRANDS HOLDINGS INC.
Effective
2026-04-24
Filed
May 4, 2026, 7:59 PM ET
On April 24, 2026, during a telephonic discussion with members of the Board of Directors (the “Board”) of Sentient Brands Holdings Inc. (the “Company”), George Furlan informed the Board of his resignation, effective April 24, 2026, from his positions as Interim Chief Executive Officer of the Company and as a member of the Board.
Appointed (interim)

Laura C. Holson

interim Chief Financial Officer and Treasurer
NMFC · New Mountain Finance Corp
Effective
2026-05-29
Filed
May 4, 2026, 7:59 PM ET
the Board of Directors (the “Board”) of the Company appointed Laura C. Holson as the interim Chief Financial Officer and Treasurer of the Company, effective May 29, 2026.
Departed

Robert R. Dillard

Executive Vice President and Chief Financial Officer
KBH · KB HOME
Effective
2026-05-08
Filed
May 1, 2026, 7:59 PM ET
On April 29, 2026, Robert R. Dillard, KB Home ’ s Executive Vice President and Chief Financial Officer, resigned from his position, effective May 8, 2026.
Appointed

Nichlas A. Fink

Senior Vice President and Chief Accounting Officer
CSCO · CISCO SYSTEMS, INC.
Effective
2026-05-20
Filed
May 1, 2026, 7:59 PM ET
On April 27 , 2026, the Board of Directors of Cisco appointed Nichlas A. Fink to succeed Ms. Wong as Senior Vice President and Chief Accounting Officer of Cisco effective May 20, 2026.
Departed

M. Victoria Wong

Senior Vice President and Chief Accounting Officer
CSCO · CISCO SYSTEMS, INC.
Effective
2026-05-19
Successor
Nichlas A. Fink
Filed
May 1, 2026, 7:59 PM ET
On April 27, 2026, M. Victoria Wong notified Cisco Systems, Inc. ("Cisco") of her decision to retire as Senior Vice President and Chief Accounting Officer of Cisco effective May 19, 2026.
Role change

Ryan D. Campbell

Acting Chief Financial Officer
DE · DEERE & CO
Effective
2026-05-01
Successor
T. Brent Norwood
Filed
May 1, 2026, 7:59 PM ET
Mr. Norwood replaces Ryan D. Campbell, who was acting Chief Financial Officer and will continue as President, Worldwide Construction & Forestry and Power Systems for the Company.
Appointed

Shao-Lee Lin

President and Chief Executive Officer
CUE · Cue Biopharma, Inc.
Effective
2026-04-30
Filed
May 1, 2026, 7:59 PM ET
On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026
Departed (interim)

Lucinda Warren

Interim President and Chief Executive Officer
CUE · Cue Biopharma, Inc.
Effective
2026-04-30
Successor
Shao-Lee Lin
Filed
May 1, 2026, 7:59 PM ET
Dr. Lin will succeed Lucinda Warren whose resignation as Interim President and Chief Executive Officer was effective as of April 30, 2026
Appointed

Sharon Price John

Chief Executive Officer and President
CRI · CARTERS INC
Effective
2026-06-15
Successor
Sharon Price John
Filed
May 1, 2026, 7:59 PM ET
On May 1, 2026, the Company announced that the Board of Directors of the Company (the “Board”) approved the appointment of Sharon Price John as Chief Executive Officer and President of the Company and a member of the Board, effective June 15, 2026
Appointed

Michael H. Rogers

Chief Financial Officer and Treasurer
ULH · UNIVERSAL LOGISTICS HOLDINGS, INC.
Effective
2026-06-01
Filed
May 1, 2026, 7:59 PM ET
Michael H. Rogers was appointed to serve as Chief Financial Officer and Treasurer of the Company, effective June 1, 2026.
Appointed

Cary Vance

President and Chief Executive Officer
RCEL · AVITA Medical, Inc.
Effective
2026-04-30
Filed
May 1, 2026, 7:59 PM ET
the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026
Appointed

Ben Landen

Chief Executive Officer
ARCI · Archimedes Tech SPAC Partners III Co.
Effective
2026-04-28
Filed
May 1, 2026, 7:59 PM ET
On the same date, Ben Landen was appointed as the Chief Executive Officer by the Company’s board of directors, effective immediately.
Role change

Long Long

Chief Executive Officer
ARCI · Archimedes Tech SPAC Partners III Co.
Effective
2026-04-28
Successor
Ben Landen
Filed
May 1, 2026, 7:59 PM ET
On April 28, 2026, Long Long notified the board of directors of Archimedes Tech SPAC Partners III Co. (the “Company”) of his resignation as Chief Executive Officer of the Company, effective immediately.
Appointed

Marcello Padula

Chief Executive Officer
BBCQ · Bleichroeder Acquisition Corp. II
Effective
2026-04-29
Filed
May 1, 2026, 7:59 PM ET
Marcello Padula, the Company’s currently serving Chief Operating Officer, was appointed to serve as Chief Executive Officer of the Company, effective April 29, 2026
Departed

Andrew Gundlach

President and Chief Executive Officer
BBCQ · Bleichroeder Acquisition Corp. II
Effective
2026-04-29
Successor
Marcello Padula
Filed
May 1, 2026, 7:59 PM ET
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
Departed

Ryan Carhart

Vice President, Chief Financial Officer, Treasurer and Secretary
LVO · LiveOne, Inc.
Effective
2026-05-01
Successor
Craig Christensen
Filed
May 1, 2026, 7:59 PM ET
Mr. Carhart’s departure was not as a result of any dispute with the Company.
Appointed (interim)

Craig Christensen

Interim Chief Financial Officer, Interim Treasurer and Interim Secretary
PODC · PodcastOne, Inc.
Effective
2026-05-01
Filed
May 1, 2026, 7:59 PM ET
Effective as of May 1, 2026 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Craig Christensen as the Company’s Interim Chief Financial Officer, Interim Treasurer and Interim Secretary, to succeed Ryan Carhart
Departed

Ryan Carhart

Chief Financial Officer, Treasurer and Secretary
PODC · PodcastOne, Inc.
Effective
2026-05-01
Successor
Craig Christensen
Filed
May 1, 2026, 7:59 PM ET
Effective as of May 1, 2026 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Craig Christensen as the Company’s Interim Chief Financial Officer, Interim Treasurer and Interim Secretary, to succeed Ryan Carhart, the former Chief Financial Officer, Treasurer and Secretary of the Company, who notified the Company on April 28, 2026 that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Appointed

Xiaomin Chen

Chief Executive Officer, director and Chairman of the Board
ADVB · Advanced Biomed Inc.
Effective
2026-04-28
Filed
May 1, 2026, 7:59 PM ET
the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.
Departed

Yi Lu

Chief Executive Officer, director and Chairman of the Board
ADVB · Advanced Biomed Inc.
Successor
Xiaomin Chen
Filed
May 1, 2026, 7:59 PM ET
The Company and Mr. Yi Lu, the Company’s Chief Executive Officer, director and Chairman of the Board, have mutually agreed that a leadership transition is necessary and in the best interests of the Company.
Role change

Todd W. Fister

Executive Vice President, Chief Financial and Operating Officer
OC · Owens Corning
Effective
2026-05-01
Filed
May 1, 2026, 7:59 PM ET
On April 28, 2026, the Board of Directors of Owens Corning (the “Company”) promoted Todd W. Fister to Executive Vice President, Chief Financial and Operating Officer, effective as of May 1, 2026.
Departed (interim)

Michael E. Fortin

Chief Financial Officer
NAII · NATURAL ALTERNATIVES INTERNATIONAL INC
Effective
2026-05-15
Successor
Kenneth E. Wolf
Filed
May 1, 2026, 7:59 PM ET
Michael E. Fortin has given his notice of resignation as the Chief Financial Officer of the Company effective May 15, 2026.
Appointed

Jennifer Kartychak

Chief Financial Officer
WKSP · Worksport Ltd
Effective
2026-05-01
Filed
May 1, 2026, 7:59 PM ET
On April 30, 2026, the Board appointed Jennifer Kartychak as the Company’s Chief Financial Officer, effective May 1, 2026.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.